Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-05 Ball Titus B. Principal Accounting Officer Grant or award +24,427 47,905
2024-06-05 Ball Titus B. Principal Accounting Officer Grant or award · Share Option (Right to Buy) +15,340 15,340
2024-06-05 Wu Xiaobin President, COO & GM China Grant or award +253,409 1,268,849
2024-06-05 Wu Xiaobin President, COO & GM China Grant or award · Share Option (Right to Buy) +477,386 477,386
2024-06-05 Wang Lai Global Head of R&D Grant or award +168,935 1,768,962
2024-06-05 Wang Lai Global Head of R&D Grant or award · Share Option (Right to Buy) +318,253 318,253
2024-06-05 Lee Chan Henry SVP, General Counsel Grant or award +98,085 269,399
2024-06-05 Lee Chan Henry SVP, General Counsel Grant or award · Share Option (Right to Buy) +184,795 184,795
2024-06-05 Dugan Margaret Director Grant or award +16,341 45,955
2024-06-05 Dugan Margaret Director Grant or award · Share Option (Right to Buy) +34,151 34,151
2024-06-05 BRANDICOURT OLIVIER Director Grant or award +16,341 16,341
2024-06-05 BRANDICOURT OLIVIER Director Grant or award · Share Option (Right to Buy) +34,151 34,151
2024-06-05 HOOPER ANTHONY C Director Grant or award +16,341 53,755
2024-06-05 HOOPER ANTHONY C Director Grant or award · Share Option (Right to Buy) +34,151 34,151
2024-06-05 OYLER JOHN Chief Executive Officer Grant or award +490,464 1,812,018
2024-06-05 OYLER JOHN Chief Executive Officer Grant or award · Share Option (Right to Buy) +923,975 923,975
2024-06-05 Glazer Donald W. Director Grant or award +16,341 2,718,464
2024-06-05 Glazer Donald W. Director Grant or award · Share Option (Right to Buy) +34,151 34,151
2024-06-05 Riva Alessandro Director Grant or award +16,341 45,955
2024-06-05 Riva Alessandro Director Grant or award · Share Option (Right to Buy) +34,151 34,151

Page 39 of 71 · 1,406 trades